Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Humana Says Obamacare Sign-Ups Are Skewing Toward Sick

Jan. 10 (Bloomberg) -- Humana Inc. said it expects new Obamacare customers to be sicker and costlier than anticipated, after the U.S. government’s decision to let healthier people keep their existing plans.

Enrollees through the Patient Protection and Affordable Care Act’s insurance exchanges will be “more adverse than previously expected,” Humana said in a regulatory filing yesterday. While affirming its 2014 profit forecast, the Louisville, Kentucky-based health insurer said it was evaluating expectations for the new year.

Facing a wave of policy cancellations triggered by the higher standards of the Affordable Care Act, President Barack Obama said in November he would let people keep their existing health plans for an extra year. Analysts and insurers said the move might upset the financial stability of the exchanges by allowing younger, healthier customers to opt out of Obamacare.

“Humana was already assuming the exchange business would be unprofitable,” Carl McDonald, a Citigroup analyst, said in a note to clients today. “It now appears Humana believes it could lose even more money because the mix of exchange enrollment is less favorable than anticipated.”

The company also said it expects steeper funding cuts in the government’s Medicare Advantage program, which pays private insurers to provide benefits to the elderly. Proposed payments for 2015 plans will be announced next month, and Humana now estimates they will be cut by 6 percent to 7 percent, compared with an initial 4 percent to 5 percent projection.

Pricier Plans

Humana reiterated its 2014 earnings forecast of $7.25 to $7.75 a share. The company sees sales and enrollment ahead of expectations for Medicare Advantage plans this year, as well as for Medicare prescription drug plans.

The company fell 2.1 percent to $96.96 at the close of New York trading, the biggest single-day decline in three months. The shares have gained 40 percent in the last 12 months.

Humana’s exchange offerings lean toward higher-price plans with more generous coverage, so it’s unclear what the company’s warnings say for the rest of the system, McDonald said.

“It’s worth asking the question of whether Humana believes the entire exchange risk pool is worse than anticipated,” McDonald wrote, or whether the company’s own mix of products is partly to blame.

To contact the reporter on this story: Alex Nussbaum in New York at anussbaum1@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.